Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
RISPERIDONA TEVA 25 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG
Injection
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- RISPERIDONA — 25 mg
- Pharmaceutical form Home Med Cabinet grouping
- Injection
- Availability in Spain
- The only pack is marketed
Packs
RISPERIDONA TEVA 25 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG, 1 vial + 1 jeringa pregargada de disolvente + 1 adaptador vial + 2 agujas
1 pcs
National code
Marketed730204Strength of this pack 25 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 85706Official data
- Marketing authorisation holder
- TEVA GMBHOfficial data
- Authorised
- Jan 20, 2021Official data
- Authority form code
- 300Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.